Bonus Biogroup (BONS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.402x

Based on the latest financial reports, Bonus Biogroup (BONS) has a cash flow conversion efficiency ratio of 2.402x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-4.02 Million ≈ $-10.79K USD) by net assets (ILA-1.68 Million ≈ $-4.49K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BONS company net worth for the company's overall valuation and market capitalisation.

Bonus Biogroup - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Bonus Biogroup's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bonus Biogroup Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bonus Biogroup ranked by their cash flow conversion efficiency. Explore BONS cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Gozco Plantations Tbk JK:GZCO	-0.010x
Pungguk Ethanol Industrial Co. Ltd KQ:023900	0.005x
Eugene SPAC 1 KQ:187790	0.086x
Cingulate Inc NASDAQ:CING	-1.434x
Company K Partners Limited KQ:307930	0.108x
Tex Cycle Technology M Bhd KLSE:0089	0.002x
Thantawan Industry Public Company Limited BK:THIP	-0.005x
Cedergrenska AB ST:CEDER	0.055x

Annual Cash Flow Conversion Efficiency for Bonus Biogroup (2008–2025)

The table below shows the annual cash flow conversion efficiency of Bonus Biogroup from 2008 to 2025. View BONS live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA-5.66 Million ≈ $-15.18K	ILA-14.93 Million ≈ $-40.03K	2.636x	+185.81%
2024-12-31	ILA6.96 Million ≈ $18.65K	ILA-21.37 Million ≈ $-57.30K	-3.072x	-241.08%
2023-12-31	ILA29.30 Million ≈ $78.57K	ILA-26.40 Million ≈ $-70.77K	-0.901x	-76.27%
2022-12-31	ILA56.39 Million ≈ $151.18K	ILA-28.82 Million ≈ $-77.25K	-0.511x	-8.30%
2021-12-31	ILA84.43 Million ≈ $226.35K	ILA-39.84 Million ≈ $-106.81K	-0.472x	+8.05%
2020-12-31	ILA30.68 Million ≈ $82.26K	ILA-15.75 Million ≈ $-42.21K	-0.513x	-153.70%
2019-12-31	ILA-13.72 Million ≈ $-36.79K	ILA-13.11 Million ≈ $-35.16K	0.956x	-77.39%
2018-12-31	ILA-3.18 Million ≈ $-8.52K	ILA-13.43 Million ≈ $-36.00K	4.226x	+128.21%
2017-12-31	ILA-6.38 Million ≈ $-17.12K	ILA-11.82 Million ≈ $-31.70K	1.852x	+41.67%
2016-12-31	ILA-7.36 Million ≈ $-19.74K	ILA-9.62 Million ≈ $-25.80K	1.307x	-77.50%
2015-12-31	ILA-1.39 Million ≈ $-3.72K	ILA-8.07 Million ≈ $-21.63K	5.809x	+144.38%
2014-12-31	ILA604.00K ≈ $1.62K	ILA-7.91 Million ≈ $-21.20K	-13.091x	-1005.65%
2013-12-31	ILA6.45 Million ≈ $17.28K	ILA-7.63 Million ≈ $-20.46K	-1.184x	+8.53%
2012-12-31	ILA7.47 Million ≈ $20.03K	ILA-9.67 Million ≈ $-25.93K	-1.294x	-132.19%
2011-12-31	ILA-881.00K ≈ $-2.36K	ILA-3.54 Million ≈ $-9.50K	4.022x	+7812.81%
2010-12-31	ILA-38.19 Million ≈ $-102.39K	ILA-1.94 Million ≈ $-5.20K	0.051x	-63.07%
2009-12-31	ILA-9.38 Million ≈ $-25.15K	ILA-1.29 Million ≈ $-3.46K	0.138x	-92.04%
2008-12-31	ILA11.86 Million ≈ $31.81K	ILA20.52 Million ≈ $55.01K	1.730x	--

About Bonus Biogroup

TA:BONS Israel Biotechnology

Market Cap

$62.31 Million

ILA23.24 Billion ILA

Market Cap Rank

#21128 Global

#278 in Israel

Share Price

ILA19.90

Change (1 day)

+13.07%

52-Week Range

ILA17.20 - ILA58.50

All Time High

ILA171.00